Unresectable/Metastatic Colorectal Cancer
13 clinical trials · Condition
◉ Watch Unresectable/Metastatic Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer (NCT04991948) | Celyad Oncology SA | 2021-11-22 |
| A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx (NCT05068206) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-10-08 |
| Probiotics Combined With Standard Chemotherapy Plus Targeted Therapy in Patients With Metastatic Colorectal Cancer (NCT04131803) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-10-01 |
| mXELOXIRI Combined With Molecular Targeted Drug in mCRC (NCT04160416) | First Affiliated Hospital of Zhejiang University | 2019-07-01 |
| OPTIMOX-aflibercept as First-line Therapy in Patients With Unresectable Metastatic Colorectal Cancer (NCT01802684) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2013-05-01 |
Track Unresectable/Metastatic Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.